(Q33975896)

English

Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model (English)

1 reference

Europe PubMed Central

30 July 2017

Pseudomonas aeruginosa

object named as

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

author name string

D M Cappelletty

1

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

30 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

30 July 2017

43

1 reference

Europe PubMed Central

30 July 2017

129-133

1 reference

Europe PubMed Central

30 July 2017

1

1 reference

Europe PubMed Central

30 July 2017

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

LAGRAN program for area and moments in pharmacokinetic analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

Pharmacokinetics of cefepime in subjects with renal insufficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

Novel method for measurement of outer membrane permeability to new beta-lactams in intact Enterobacter cloacae cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

Pharmacokinetic disposition and bactericidal activities of cefepime, ceftazidime, and cefoperazone in serum and blister fluid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

5 July 2018

Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89032

29 October 2018

Effect of the ratio of surface area to volume on the penetration of antibiotics in to extravascular spaces in an in vitro model

1 reference

https://pubmed.ncbi.nlm.nih.gov/9869577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of surface area/volume ratio on the kinetics of antibiotics in different tissues and tissue fluids

1 reference

https://pubmed.ncbi.nlm.nih.gov/9869577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and tissue penetration of cefepime

1 reference

https://pubmed.ncbi.nlm.nih.gov/9869577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/9869577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of bacterial isolates to beta-lactam antibiotics from U.S. clinical trials over a 5-year period

1 reference

https://pubmed.ncbi.nlm.nih.gov/9869577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/JAC/43.SUPPL_1.129

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

reason for deprecated rank

incorrect identifier value

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33975896&oldid=1966978955"